4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Renal Impairment: new trials by email Literature Review of Renal Impairment trials Research Report on Renal Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function Enoxaparin 20Mg/0.2mL Prefilled Syringe, Enoxaparin 60Mg/0.6Ml Inj Syringe 0.6Ml - Venous Thromboembolism, Renal Impairment | Phase 4 | Completed | Lebanese American University | 32 | 2015-10-24 | 2017-09-11 |
| An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment Deferiprone - Renal Impairment | Phase 4 | Completed | ApoPharma | 32 | 2013-01-01 | 2014-08-26 |
| Safety of Gadovist in Renally Impaired Patients Gadobutrol (Gadovist, BAY86-4875) - Fibrosis, Renal Impairment | Phase 4 | Completed | Bayer | 927 | 2008-12-01 | 2016-02-18 |
| Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography Iodixanol 320 mgI/mL - Coronary Artery Disease, Renal Impairment | Phase 4 | Completed | GE Healthcare | 408 | 2005-08-01 | 2007-10-31 |
Renal Insufficiency (4) · Coronary Artery Disease (1) · Fibrosis (1) · Kidney Diseases (1) · Venous Thromboembolism (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Kidney Diseases (3) · Cardiovascular Diseases (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Coronary Disease (1) · Embolism and Thrombosis (1) · Heart Diseases (1) · Myocardial Ischemia (1) · Pathologic Processes (1)
Deferiprone (1) · Enoxaparin (1) · Isoflurophate (1) · Long Interspersed Nucleotide Elements (1) · gadobutrol (1)
ApoPharma (1) · Bayer (1) · GE Healthcare (1) · Lebanese American University (1)
Canada (2) · Australia (1) · Austria (1) · France (1) · Germany (1) · Italy (1) · Lebanon (1) · South Korea (1) · Spain (1) · Sweden (1) · Switzerland (1) · Thailand (1)
Caroline Widlund, BSc RN (1) · Fernando Tricta, MD (1) · Johnny Gibbs, Jr., B.S., CCRA (1) · Nibal R Chamoun, PharmD (1)
2008 (1)